| |
| Magyar Sebész Társaság |
|
| 10th EFR (European Federation for coloRectal Cancer Congress) April - 20-22, 2017 Vienna |
 Rendezvény kezdete: 2017.04.20. | Rendezvény vége: 2017.04.22. |
| Szakterület(ek): Sebészet |
| Helyszín: Austria, Vienna, |
| A rendezvény Web oldala: http://www.efrcancer.org/ |
It is a great pleasure and honour to invite you to the 10th EFR – European Federation for coloRectal Cancer Congress to be held from April 20 - 22, 2017 at the Medical University of Vienna. This congress will address state-of-the-art multidisciplinary management of colorectal cancer. The optimal method to diagnose and treat this common cancer requires a multimodality approach: perspectives from endoscopy, pathology, surgery, medical oncology, radiation medicine and biomarker assessment. The symposium sessions will be including life surgeries, hands-on workshop, scientific paper and video presentations.
Apart from a famous Viennese environment during the most beautiful time of the year and a touch of Austrian hospitality, this biannual EFR Conference will prove to be a wonderful opportunity for Colorectal Surgeons from all over the world to get together, learn from each other, and exchange knowledge and experience.
Highlights
• Minimal access colorectal surgery including robotics and laparoscopy
• NOTES and trans-anal access surgery
• Novel Findings in Molecular Biology
• New Horizons in Recent Studies
• Latest Developments in Molecular Imaging
• Translational Medicine approaches in Drug Development
We look forward to welcoming you to an inspiring congress in Vienna 2017.
Website: http://www.efrcancer.org/ >>
Yours sincerely,
Béla Teleky
MD, FRCS
President of the EFR
|
|
|
 |
| |
| Magyar Sebész Társaság |
|
| European Federation of Colorectal Cancer - 10th EFR Congress (Vienna, Austria, April 20-22, 2017) |
| Rendezvény kezdete: 2017.04.20. | Rendezvény vége: 2017.04.22. |
| Szakterület(ek): Sebészet |
| Helyszín: Austria, Vienna, |
| A rendezvény Web oldala: https://www.efrcancer.org/ |
It is a great pleasure and honour to invite you to the 10th EFR – European Federation for coloRectal Cancer Congress to be held from April 20 - 22, 2017 at the Medical University of Vienna. This congress will address state-of-the-art multidisciplinary management of colorectal cancer. The optimal method to diagnose and treat this common cancer requires a multimodality approach: perspectives from endoscopy, pathology, surgery, medical oncology, radiation medicine and biomarker assessment. The symposium sessions will be including life surgeries, hands-on workshop, scientific paper and video presentations.
Apart from a famous Viennese environment during the most beautiful time of the year and a touch of Austrian hospitality, this biannual EFR Conference will prove to be a wonderful opportunity for Colorectal Surgeons from all over the world to get together, learn from each other, and exchange knowledge and experience.
Highlights:
• Minimal access colorectal surgery including robotics and laparoscopy
• NOTES and trans-anal access surgery
• Novel Findings in Molecular Biology
• New Horizons in Recent Studies
• Latest Developments in Molecular Imaging
• Translational Medicine approaches in Drug Development
We look forward to welcoming you to an inspiring congress in Vienna 2017.
Yours sincerely,
Béla Teleky
MD, FRCS
President of the EFR
More details on the website >>
Scientific programme >>
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| International Complement Workshop |
| Rendezvény kezdete: 2012.10.10. | Rendezvény vége: 2012.10.15. |
| Tudományos információ: John D. Lambris, Ph.D. |
| Címe: Department of Pathology & Laboratory Medicine
University of Pennsylvania
401 Stellar Chance
422 Curie Boulevard
Philadelphia, PA 19104 |
| Tel: 215-746-5765 |
| Fax: 215-573-8738 |
| E-mail: lambris@upenn.edu |
| Helyszín: Görögország, Chania, Crete, Minoa Palace Hotel 5* |
| A rendezvény Web oldala: http://www.complement2012.org/index.html |
XXIV. International Complement Workshop
Awards:
-Trainee Travel Awards
-The Lambris Complement Training Award (LCTA)
-Young Investigator Awards for Research in Complement
Keynote Lectures
Hans J. Müller-Eberhard Memorial Lecture
The humoral arm of innate immunity: recurrent themes and regulatory pathways
Alberto Mantovani, M.D.
Professor, University of Milan
Scientific Director, Istituto Clinico Humanitas
Systems Biology and Innate Immunity
Shankar Subramaniam, Ph.D.
Professor and Chair Department of Bioengineering,
University of California, San Diego
Tipping complex systems from disease to health: genetic and dietary influences on metabolic disease, cancer and inflammation
Joe Nadeau, Ph.D.
Director of Research and Academic Affairs
Systems Biology Institute, Seattle
|
|
|
|
| |
| Magyar Immunológiai Társaság |
|
| DC2012 - 12th International Symposium on Dendritic Cells |
| Rendezvény kezdete: 2012.10.07. | Rendezvény vége: 2012.10.11. |
| Munkahely neve: DC 2012 Secretariat |
| Címe: 1F Haeoreum B/D 748-5 Yeoksam-dong
Gangnam-gu Seoul 135-925 Korea |
| Tel: +82-2-577-8422,8423 |
| Fax: +82-2-566-6087 |
| E-mail: dc@people-x.com |
| Helyszín: Korea, Daegu, EXCO Convention Center |
| A rendezvény Web oldala: http://www.dc2012.kr/ |
The 12th International Symposium on Dendritic Cells
The DC2012 is hosted by the Korean Association of Immunologists and organized by the
Organizing Committee of the DC 2012.
The DC 2012 is anticipating more than 1,600 participants and industry representatives from 40
different countries. I truly believe that DC2012 would be the milestone for all of us to understand the
cutting-edge of research trends, to share valuable information and to build a network between
specialists in the field of dendritic cells.
Deadline of Abstract Submission is extended to June 30, 2012
re-registration: Extended to Sep. 14th, 2012!
Clinical Trial Satellite Meeting(Sponsored by JW CreaGene, BD)
*Date & Time: October 8~9, 2012 / 12:20~13:20
*Venue: 4F Auditorium, EXCO
*Confirmed Speakers:
1)TriMix Dentritic cell therapy in Melanoma - the Brussels`s experience
-Prof. Thielemans Kris (Vrije Universiteit Brussel, Belgium)
2)Applying Lessons learned from Provenge to the development of new immunotherapies for cancer
-Dr. James B. Trager (Dendreon Corporation, USA)
-The lunch will be served during the Clinical Trial Satellite Meeting.
-Maximum 300 persons can attend the meeting on a first-come, first-served basis. |
|
|
|
